跳转至内容
Merck
CN

APP788

HPLC-DAD Analysis of Metformin Hydrochloride on Ascentis® Express C18 HPLC Column

登录查看公司和协议定价

技术

HPLC: suitable

试验参数

column: Ascentis® C18, 25 cm × 4.6 mm I.D., 5 μm particle size (581325-U)
mobile phase: [A] 20 mM Potassium hexafluorophosphate in water; [B] Methanol
gradient: 95%A to 55%A in 8min, 8-10 min 55%A, 10-16 min 95%A
flow rate: 1.0 mL/min
column temp.: 25 °C
detector: (DAD, wavelength: 230 nm)
injection: (5 µL)
sample/matrix: 0.1 mg/mL in water (PHR1084)

应用

pharmaceutical

一般描述

Metformin is a biguanide hypoglycemic agent and an oral antidiabetic medication widely used in the treatment of type 2 diabetes. It is effective in glycemic control and decreases the intestinal absorption of glucose, without the problem of serious lactic acidosis.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. They are provided with a comprehensive Certificate of Analysis (COA) included a certified value and expanded uncertainty according to ISO 17034. Additionally, traceability to the current batch of Compendial Reference Standards from USP, EDQM and/or BP is provided, as available.
sigmaaldrich.com/pharmastandards

其他说明

APP_788

法律信息

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门